Can eculizumab be discontinued in aHUS? Case report and review of the literature

Author(s):
Sahutoglu, T.; Basturk, T.; Sakaci, T.; Koc, Y.; Ahbap, E.; Sevinc, M.; Kara, E.; Akgol, C.; Caglayan, F.B.; Unsal, A.; Daha, M.R. (0000-0002-0113-0750)
Published
2016
Publication type
Article / Letter to editor
aHUSeculizumabmutation of complement factors
Date issued
2016-08-31
Language
English
Is part of
Medicine (2016), No. 31
hdl
1887/113687
doi
10.1097/MD.0000000000004330